← Evidence map

ArticleJournal of biomedical science2022

Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer.

Jai-Shin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35534851